New ARTEMISA infrastructure call for artificial intelligence calculations

The new call for applications to use the Artemisa infrastructure for research work requiring artificial intelligence and machine learning calculations will be open from 15 May to  9 June of 2024.

In this call, all research groups from Spanish public universities and public research organisations may apply for the use of the infrastructure.

Artemisa currently has 23 servers each hosting an NVIDIA Volta V100 GPU, 11 servers with an NVIDIA Ampere A100 GPU and one server with 8 NVIDIA Ampere A100 GPUs. The servers are especially suited for artificial intelligence computations. In addition to these servers, which are to be used in batch mode, two interfaces are available where users can pre-test their programs. It also has a state-of-the-art storage system and state-of-the-art CPUs.

Groups wishing to use Artemisa should apply on its website: href=”https://artemisa.ific.uv.es/”>https://artemisa.ific.uv.es/

following the instructions given therein.

Applications will be evaluated by a committee that will take into account the scientific interest of the proposals, the track record of the proposing group, the suitability of the calculations to the use of Artemisa resources, in particular the use of artificial intelligence, and the availability of infrastructure. Additionally, its social impact may be taken into account, especially if the objectives of the project are included in the RIS3 priority matrix of the Valencian Region.

ARTEMISA is co-financed by the European Union and the Conselleria d’Educació, Universitats i Ocupació of the Generalitat Valenciana through the project IDIFEDER/2018/048 of the Operational Programme ERDF 2014-2020 of the Comunitat Valenciana. With the support of the Ministry MCIU with funds from the European Union NextGenerationEU (PRTR-C17.I01) and the Generalitat Valenciana (ASFAE/2022/024).

HYBRIMS, a spin-off of IFIC (Universitat de València and CSIC), develops devices for accurate diagnosis and improved prognosis of cancer patients

Source: UVNoticies

A new spin-off of the Universitat de València (UV) and the Spanish National Research Council (CSIC) will bring to market a biomedical imaging device for real-time guidance of cancer biopsies. The technology used, industrially owned jointly by both public institutions, provides combined metabolic and morphological data that allow a much more accurate characterisation of tumours. The system also facilitates personalised diagnosis and treatment for cancer patients.

The patent licensed by UV and CSIC to the company HYBRID IMAGING SYSTEMS S.L. (HYBRIMS) refers to a novel medical device that makes it possible to select, for the first time in real time, the most active and aggressive parts of tumours during cancer biopsies.

The technology on which this equipment is based addresses cancer diagnosis by combining, in a single device and live, clinical images that until now have only been available separately and sequentially. The new system effectively combines gamma and ultrasound imaging, providing metabolic and morphological information of the tumour or sentinel lymph node in a hybrid image, visualising its most active or aggressive areas and enabling real-time cancer biopsy guidance. This gives medical teams a deeper understanding of the tumour and reduces overall treatment costs.

“Through this advance in biomedical imaging, we are taking a step forward towards precision medicine, as the system allows for precise and personalised oncological treatment”, comments Luis Caballero, a scientific researcher at the Institute of Corpuscular Physics (IFIC, a joint UV-CSIC centre) and main promoter of the company. “In addition to improving the diagnosis and prognosis of cancer patients, this new technology will reduce the number of false positives and negatives, which will help to reduce the stress and anxiety of those affected”, adds the researcher. The new device will be mobile, compact, lightweight and, therefore, highly operational.

Established as a limited liability company (S.L.), HYBRID IMAGING SYSTEMS S.L. has been recognised this Tuesday 7th May as a spin-off of the University of Valencia and CSIC. Both institutions participate, together with the promoters, in the share capital of the new spin-off.

 

Collaborative research in joint spin-offs

The Universitat de València currently has 23 active spin-offs, mainly in the fields of Life Sciences, Engineering and Technology. Since 2005, the number of companies recognised by the institution has continued to grow and expand its fields of action, in line with its status as a generalist university.

Thus, companies derived from research in Social Sciences and Humanities, or companies in the fields of Chemical Industry, Optical Instrumentation or Physical Instrumentation, for applications in sectors such as biotechnology, biomedicine or electronics, among others, are now added to the catalogue of spin-offs of the University of Valencia; a catalogue that, since the beginning of 2024, reveals an increasingly collaborative research model, with the consequent generation of joint institutional patents.

HYBRIMS is the second joint spin-off that the UV recognises this year and the first in collaboration with the Spanish National Research Council (CSIC).